<DOC>
	<DOCNO>NCT00939029</DOCNO>
	<brief_summary>Smokeless tobacco use ( `` chew '' ) associate negative health effect . To date , medication show help chewer quit long-term . High dose nicotine patch therapy may improve chance chewer quit good . If find effective , chewer may use treatment help quit reduce risk negative health effect .</brief_summary>
	<brief_title>Highdose Nicotine Patch Therapy Smokeless Tobacco Use</brief_title>
	<detailed_description>Approximately 8.2 million ( 3.3 % ) Americans ≥ 12 year age current smokeless tobacco ( ST ) user , prevalence ST use increase past three year . ST increasingly promote harm reduction strategy cigarette smoking , two world 's large cigarette manufacturer enter ST market . ST use estimate great exogenous source human exposure cancer-causing nitrosamines . ST associate oral extra-oral cancer well cardiovascular cerebrovascular mortality . A need efficacious intervention exist 64 % ST user report desire quit . However , pharmacotherapy proven efficacy increase long-term ( &gt; 6 month ) tobacco abstinence rate among ST user compare placebo . New pharmacotherapies , drug combination , improve dose exist pharmacotherapies need . Previous research nicotine patch ST user use standard dos ( 21 mg/day ) increase long-term abstinence rate . However , study higher dose nicotine patch therapy ( 63 mg/day ) ST user demonstrate dose-dependent reduction tobacco withdrawal symptom well preliminary evidence increase long-term ( &gt; 6 month ) abstinence rate compare low dos . The purpose study evaluate efficacy high dose nicotine patch therapy ( 42 mg/day ) increase 7-day point prevalence prolong tobacco ST abstinence rate end-of-treatment ( week 8 ) , 12 24 week compare placebo ST user use ≥ 3 cans/pouches per week subject receive behavioral treatment tobacco dependence . To accomplish aim , randomize 60 ST user clinical pilot study . The work conduct Mayo Clinic Rochester , MN .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Lobeline</mesh_term>
	<criteria>1. least 18 year age 55 year age ; 2. report daily ST use past 12 month ; 3. identify ST primary tobacco product ; 4. use average ≥ 3 cans/pouches per week ; 5. general good health ( determined medical history screen physical examination ) ; 6. provide , understand , sign informed consent . 1. currently use ( past 30 day ) behavioral pharmacologic tobacco treatment program ; 2. currently pregnant lactating ; 3. unstable angina , myocardial infarction , coronary angioplasty within past 3 month ; 4. history arrhythmia abnormal trace baseline EKG ; 5. blood pressure great 140/90 pulse 110 beat per minute ; 6. history severe skin allergy dermatoses ; 7. history intolerance nicotine patch ; 8. another member household already participate study ; 9. take medication know interact nicotine ( i.e. , clozapine ) ; 10. take prescription medication depression asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>tobacco use</keyword>
	<keyword>smokeless tobacco</keyword>
	<keyword>chew tobacco</keyword>
	<keyword>snuff</keyword>
	<keyword>nicotine replacement</keyword>
	<keyword>tobacco dependence</keyword>
	<keyword>tobacco cessation</keyword>
	<keyword>tobacco abstinence</keyword>
</DOC>